Filing Flows

Filing Flows › Ultralife (ULBI) › Q2 2026

Ultralife (ULBI) Q2 2026 earnings results (second quarter 2026)

10-Q filed Aug 7, 2026

Ultralife (ULBI) reported revenue of $47.9M for the second quarter 2026 (Q2 2026), -1% from a year earlier and +1% from the quarter before. Operating margin was 7.2%, net earnings $2.5M (5.3% of revenue).

Revenue$47.9M
Year over year-1%
Quarter over quarter+1%
Operating margin7.2%
Net earnings$2.5M

Ultralife, Q2 2026: revenue $47.9M (-1% year over year), operating margin 7.2%, net earnings $2.5M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.

Q2 2026AmountQ/QY/Y
Revenue$47.9M+1%-1%
Gross profit$13.9M+37%+20%
Operating profit$3.4M—+52%
Net earnings$2.5M—+189%
Operating cash flow$1.2M-47%-80%
Free cash flow$735K-51%-85%

What changed

Revenue was $47.9M in Q2 2026, down 1% year over year and up 1% from the previous quarter. Battery & Energy Products Segment was the largest line at 92% of revenue. Battery & Energy Products Segment lost $1.7M year over year (down 4%), 272% of the total change.

Gross margin was 28.9%, up 5.0 points from Q2 2025. Operating profit was $3.4M, a 7.2% margin (up 2.5 points year over year). Operating expenses grew 12% against a revenue fall of 1%. The fastest-growing cost line was Research & development (+39%). Net earnings were $2.5M, up 189% year over year. The effective tax rate was 15.7%.

Operating cash flow was $1.2M (down 80% year over year), 47% of net earnings. Non-cash charges added back $1.3M of depreciation and amortization and $90K of share-based compensation. Working capital and other items used $2.7M. Capital expenditures of $453K left free cash flow of $735K.

Questions

What was Ultralife's revenue in the second quarter 2026?

Ultralife (ULBI) reported revenue of $47.9M for the second quarter 2026 (Q2 2026), -1% from a year earlier and +1% from the quarter before.

Was Ultralife profitable in the second quarter 2026?

Operating profit was $3.4M (7.2% of revenue) and net earnings $2.5M.

Open the interactive Sankey →

Source: Ultralife 10-Q on SEC EDGAR.